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Abstract
Tooth loss from periodontal disease is a major public health burden in the United States.
Standard clinical practice is to recommend a dental visit every six months; however, this prac-
tice is not evidence-based, and poor dental outcomes and increasing dental insurance premiums
indicate room for improvement. We consider a tailored approach that recommends recall time
based on patient characteristics and medical history to minimize disease progression without
increasing resource expenditures. We formalize this method as a dynamic treatment regime
which comprises a sequence of decisions, one per stage of intervention, that follow a decision
rule which maps current patient information to a recommendation for their next visit time. The
dynamics of periodontal health, visit frequency, and patient compliance are complex, yet the
estimated optimal regime must be interpretable to domain experts if it is to be integrated into
clinical practice. We combine non-parametric Bayesian dynamics modeling with policy-search
algorithms to estimate the optimal dynamic treatment regime within an interpretable class of
regimes. Both simulation experiments and application to a rich database of electronic dental
records from the HealthPartners HMO shows that our proposed method leads to better dental
health without increasing the average recommended recall time relative to competing methods.
Key words: Dirichlet process prior; dynamic treatment regimes; observational data; periodon-
tal disease; practice-based setting; precision medicine; sequential optimization
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1 Introduction
Periodontal disease (PD) contributes to eventual tooth loss and remains a major health burden. The
ultimate goal of professional periodontal maintenance plans (AAP, 2001) and personal oral care is
PD prevention and maintaining teeth in a state of comfort and function. The total dental health-
care spending in the United States in 2013 was a staggering US$ 91.8 billion (Wall, Thomas and
Guay, Albert, 2016), and is continually increasing (CDC, 2010). Hence, there is an urgent need to
reduce cost without diminishing the quality of care. In the context of dental care, updating peri-
odontal recall recommendations to reflect the individual needs of each patient holds the potential
to both improve oral health and reduce cost. The length of periodontal recall intervals has been a
topic of research and debate for decades (Lo¨vdal et al., 1961; Axelsson et al., 1991; Fardal et al.,
2004; Mettes, 2005; Riley et al., 2013) with recommendations for recall intervals ranging from
two weeks (Nyman et al., 1975) to eighteen months (Rose´n et al., 1999). The current standard of
care, which was advocated as early as 1879 by the American Academy of Dental Science (Teich,
2013), is a recall interval of six months for all patients regardless of individual demographics, oral
health, family history, or other risk factors. Existing clinical guidelines recommend that the recall
intervals should depend on individual patient characteristics (NCCAC, 2004; Patel et al., 2010; see
also Giannobile et al., 2013) but offer little concrete guidance on how to map individual patient
characteristics to a recall interval.
The potential effect of altering such intervals on oral health had remained the subject of inter-
national debate for almost 3 decades (Mettes, 2005; Riley et al., 2013). Infrequent dental visits
might impair the ability to diagnose PD at an early stage, present fewer opportunities for providing
oral-care education, and block the opportunities for effective treatments (Davenport et al., 2003).
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However, unnecessary visits and treatments waste the resources and increase the cost. Therefore,
the recall interval should be tailored to individual needs. Patients at high risk may benefit from
more frequent visits while less frequent visits might be adequate for subjects without certain risk
factors of PD (Giannobile et al., 2013). This provides evidence that a personalized (or precision)
medicine approach (Kornman and Duff, 2012; Zanardi et al., 2012) might improve resource allo-
cation for preventive dentistry.
In this paper, we consider adaptive recall intervals that recommend a recall time for each patient
at each visit depending on their personal characteristics, including disease history. We formalize
a personalized recall interval policy as a function that maps current patient information to a rec-
ommended recall interval, which is an example of a dynamic treatment regime, or DTR (Murphy,
2003; Robins, 2004; Chakraborty and Moodie, 2013; Schulte et al., 2014; Kosorok and Moodie,
2015). A DTR is defined as a sequence of decision rules, one per stage of intervention, to make
treatment decisions based on the patients evolving status. Each decision rule takes the individ-
ual’s information up to that time point as the input, and outputs a recommended treatment at that
stage. The optimal DTR is defined as the regime that optimizes the mean long-term outcome. The
problem we are addressing is to specify a regime that uses a patient’s up-to-date information to
tailor recall interval recommendations in such a way that maximizes long-term population-level
benefits, and it is thus a DTR problem. DTRs have been applied across a wide range of application
domains to estimate data-driven intervention policies (van der Laan and Petersen, 2007; Robins
et al., 2008; Shortreed and Moodie, 2012; Laber et al., 2014; Almirall et al., 2014; Wu et al.,
2015); however, estimation of an optimal recall intervention policy presents several challenges
that make existing estimation methods unsuitable without modification. These challenges include:
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(i) cost constraints on recall frequency across the entire population; (ii) non-compliance and sparse
irregularly spaced clinic visits; (iii) a bounded response with a large point mass on the response
of the previous time point due to clinicians carrying forward previous measurements rather than
retaking them; and (iv) the requirement that the estimated policy be clinically interpretable, despite
complex disease dynamics. Existing methods for cost-constrained DTRs include cost-constrained
IQ-learning (Linn et al., 2016) which only applies for two decision points; cost-sensitive DTRs
(Luedtke and van der Laan, 2016) which constrain the proportion of individuals who can receive
treatment; set-valued DTRs (Laber et al., 2014; Lizotte and Laber, 2016) which allow for multi-
variate outcomes, e.g., cost and efficacy, but do not permit constrained estimation. Functional and
longitudinal methods for DTRs can accommodate sparse and irregularly-spaced observation times
(Ciarleglio et al., 2015; Lu et al., 2016; Laber and Staicu, 2016), however, these methods are not
designed for application with many, possibly outcome-driven, follow-up times, nor can they deal
with non-compliance.
Policy-search is a common method for estimation of a DTR, and is particularly well-suited
to constrained problems (Chakraborty and Moodie, 2013; Wang et al., 2018; Laber et al., 2018).
Policy-search methods postulate a model for the marginal mean outcome under each policy within
a pre-specified class of policies and choose the maximizer as the estimated optimal policy (Robins
et al., 2008; Orellana et al., 2010; Zhang et al., 012a,b; Zhao et al., 2012; Zhang et al., 2013;
Zhao et al., 2015; Kosorok and Moodie, 2015; Guan et al., 2016; Zhou and Kosorok, 2017). An
advantage of policy-search methods is that models for the underlying disease progression can be
decoupled from the class of policies, thereby allowing for complex disease models with parsimo-
nious, interpretable, or cost-constrained estimated optimal policies (Zhang et al., 2015; Laber and
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Zhao, 2015; Lakkaraju and Rudin, 2016). However, existing methods for policy-search are difficult
to implement for complex data structures, like the one we consider here.
We use a Bayesian nonparametric (BNP) disease dynamics model and g-computation (Robins,
1986) to construct an estimator of the marginal mean outcome and cost under any policy within a
pre-specified class, and then use stochastic optimization to approximate the maximizer of the mean
outcome under a constraint on cost. The marginal mean outcome is cumulative, and accounts for
disease progression and delayed effects of treatment. We estimate this marginal mean outcome
using g-computation, which accounts for these effects and other time-varying causal confounding.
The proposed dynamics model is sufficiently flexible to accommodate non-compliance, sparse
and irregularly-spaced visits; however, our class of policies is based on a clinically interpretable
risk score. BNP methods have recently been used in the context of estimating optimal treatment
regimes (Arjas and Saarela, 2010; Xu et al., 2016; Murray et al., 2017), but they did not consider
regimes that adapt to the evolving health status of each individual patient, or cost constraints.
The motivation for establishing this (recall) recommendation engine comes from analyzing an
observational database in a dental practice-based setting, collected by the HealthPartners®(HP)
Institute at Minneapolis, Minnesota. In Section 2, we review the HP data. In Section 3, we
formalize the recall estimation problem using a decision theoretic framework. In Section 4, we
present a BNP formulation of the disease dynamics and in Section 5, we combine this model with
a stochastic optimization algorithm to construct an estimator of the optimal intervention policy
subject to constraints on cost. In Section 6, we evaluate the finite sample performance of the
proposed methods using a suite of simulation experiments. We analyze the motivating HP dataset
and summarize the fitted policy in Section 7. Finally, we conclude with a brief discussion in
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Section 8.
2 HealthPartners Data
The motivating longitudinal HP dataset were collected from routine dental practice in the Min-
neapolis area. We include only adult subjects with at least two visits, giving 24,731 subjects with
as many as 8 years of irregular longtitudinal follow-up, with an average of 8.6 visits. For each sub-
ject, we use the data from the first visit until the last visit to fit the model proposed in Section 3, and
so the follow-up window varies by subject. During each visit, periodontal pocket depth (PPD) is
recorded at six pre-specified sites per tooth (excluding the third molars) giving 168 measurements
for a full mouth without any missing tooth. In concordance with the proposed standards from the
joint EU/USA Periodontal Working Group (Holtfreter et al., 2015), we use the proportion of dis-
eased/affected tooth sites (with PPD> 3mm, or missing tooth) per mouth, henceforth PMU, as our
response to measure the extent (severity) of PD. Note, when the tooth is missing, we assume the
missing is due to PD and we classify all sites associated with the missing tooth are diseased tooth
sites. So each missing tooth contributes to 6 diseased tooth sites in the calculation. Demographic
information and medical history are also collected, including age (ranging from 19 to 97 years,
with mean 55 years), gender (49% male, 51% female), race (85% white, 15% non white), dia-
betes status (8% with diabetes, 92% without diabetes), smoking status (9% current tobacco user,
91% not current user), and insurance information (80% with commercial insurance, 20% without
commercial insurance).
Figure 1 plots the longitudinal profiles for 10 subjects. Although there are some short-term
decreases, there is a clear population-level increasing trend. A high proportion of the responses are
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Figure 1: The proportion of sites with unhealthy PPD (pocket depth exceeding 3mm) or missing tooth,
denoted by PMU, over time, for 10 randomly chosen subjects.
identical to the previous response, reflecting the common practice of carrying the previous values
forward in the dental record if there is no apparent change in disease status. During each visit,
the recommended time until the next visit (A) is also recorded, and the actual time between two
visits (δ) is computed. HP uses an algorithm to classify subjects as low, medium or high risk of
PD and caries, and this risk score is taken into consideration when recommending the next visit
time. However, this risk score is not optimized for recall recommendations, and dentists are not
obliged to use it. The range of A, as indicated in Figure 2, varies significantly from 3 months
to 18 months. The figure also illustrates the partial controllability, with a strong but imperfect
relationship between observed and recommended recall times (A) between visits.
7
Figure 2: Density plots of actual time between visits (δ months) for each level of recommended recall
interval (A months).
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3 Problem statement
The data at baseline for subject i = 1, . . . , n include the p-vector of covariates, Xi and the scalar
baseline response, Yi0. At the baseline visit, a recommended number of months until the first
follow-up visit Ai1(> 0) is given. The subject returns for the first following visit δi1(> 0)
months after the baseline visit, and the subject’s response, Yi1, is recorded. This process is re-
peated for Ni follow-up visits for the subject i. The data available after visit t for subject i are
Hit = {Xi, Yi0, Ai1, δi1, Yi1, . . . , Aiti , δit, Yit}, and Hi ≡ HiNi is the entire history for subject i.
The subscript i is suppressed to denote a generic trajectory Ht = {X, Y0, A1, δ1, Y1, . . . , At, δt, Yt}.
Our objective is to use these data to determine a policy for recommending the time between
visits. A policy pi is a deterministic function that maps the available data to a recommendation,
i.e., under pi,
At = pi(Ht;α). (1)
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The policy is parameterized in terms of the unknown vector α = (α1, . . . , αq)T . For interpretabil-
ity, we assume that the policy is a function of a risk score that is a linear combination of features
constructed from Ht, f(Ht) = [f1(Ht), . . . , fq(Ht)]T . There is great flexibility in constructing the
features; they can include the covariates themselves, fk(Ht) = Xj , or composites such as change
from baseline fk(Ht) = Yt − Y0, or even summaries of the posterior predictive distribution. The
risk score is then Rt = f(Ht)Tα, and subjects with high risk scores are recommended to have
small At, whereas subjects with low risk are recommended to a larger At. While including many
features can give a rich class of policies, we consider a small value of q so that the subclass of
policies is interpretable, and the optimization problem reduces to estimating the low-dimensional
vector α. We use Π to denote the above pre-specified class of policies that are parameterized by
α.
We formalize the optimal recall interval recommendation policy within the class Π using po-
tential outcomes. Define Y ?t (at) and δ
?
t (at) to be the potential PMU outcome at visit t and po-
tential time between visit t and visit t − 1, respectively, if the sequence of recall recommen-
dations at would be given to a subject since baseline visit, where at = {a1, . . . , at} denotes
the history of recall interval recommendations up to visit t . Define Y ?t (pi), δ
?
t (pi) to be the
potential outcomes at visit t under recall interval recommendation policy pi. The value asso-
ciated with a policy can be defined as the expectation of a function of potential outcomes un-
der the policy, e.g., V (pi) = E{[1/J?(pi)]∑J?(pi)t=1 Y ?t (pi)}, where J?(pi) is the number of visits
within a pre-specified time period under policy pi. The optimal policy within the pre-specified
class of policies is piopt = arg max
pi∈Π
V (pi). In order to estimate the optimal recall interval rec-
ommendation policy within the pre-specified class using the observed data, we make the fol-
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lowing assumptions: (1) no unmeasured confounders (or sequential ignorability) (Robins, 2004),
{(Y ?k (ak), δ?k(ak)) : for all ak ∈ Ak}k≥1 ⊥⊥ At|Ht for t = 1, . . . , N , whereAk = A1×· · ·×Ak is
the set of all possible recall interval recommendations up to visit k; (2) consistency, Yt = Y ?(At)
and δt = δ?(At), where At is the sequence of observed recommended recall intervals up to visit
t, i.e., the observed outcomes are the potential outcomes under the actual given recall interval rec-
ommendation; (3) positivity, there exists  > 0 so that P (At = at|Ht = ht) ≥  for all at ∈ Ψt(ht)
and for all ht, where Ψt(ht) is the set of possible recall interval recommendations for a subject
with realized history information ht, t = 1, . . . , N . Under those assumptions, our framework of
estimating optimal policy is causally interpretable (Robins, 2004; Schulte et al., 2014), and we use
the notation of the generic trajectory instead of potential outcomes hereafter.
To compare policies, we use a utility function U(H), which is considered the primary outcome
to be optimized. Based on the underlying clinical science and logistical constraints, we chose 5-
year mean reduction in the proportion of unhealthy sites as one of our primary outcomes; however,
the proposed methodology can be extended to other time horizons, or other summaries of a patients
health trajectory. We desire a policy that applies to all subjects, and we therefore compare the
population mean utility, called the value, V (α) = Eα[U(H)]. The expectation averages over
the entire distribution of H, including the baseline covariates, the visit times as determined by
δt, and the PMU trajectory Y0, . . . , YN . The policy vector α alters the value indirectly via the
recommendation times At which subsequently affect the time courses of δt and dental health state
Yt. Therefore, estimating the value of the policy requires determining compliance relationship
(the distribution of δt given At), and the effect of recall on PD (the distribution of Yt given δt).
In addition to value, policies must be compared in terms of their cost because it is not feasible
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to recommend a short time between visits for all subjects. We control cost by constraining the
average recommended recall time to be T , C(α) = Eα(At) = T .
The objective is to identify an α which maximizes the value V (α) while maintaining cost
constraint C(α) = T . Rather than attempting to estimate α directly from the data, our approach
is to first estimate the distribution of H as a function of α using a BNP model (Section 4). Given
this model, we can then simulate from the process to obtain Monte Carlo estimates of V (α) and
C(α) for any α, and use this simulation as a basis for determining the optimal α (Section 5).
4 Bayesian model for disease progression
For our application, we build a Dirichlet Process Mixture (DPM) model that is parsimonious
enough to fit large data sets and facilitate the extensive simulation required for policy evalua-
tion, yet flexible enough to capture the complex dynamics of the HP data. Heterogeneity across
subjects is captured with subject random effects Θi = {θi0,θi1,θi2} that includes random effects
for baseline status (θi0), compliance (θi1), and disease progression (θi2), and is modeled using
Bayesian nonparametrics as described below. Given the random effects, we propose a Markov
outcome-dependent follow-up model (Ryu et al., 2007) for Hi,
(XTi , Yi0)
T |Θi ∼ Normal(θi0,Σ0) (2)
log(δit)|Θi,Xi, Yit−1, Ait ∼ Normal(X Tit θi1, σ21)
Yit|Θi,Xi, Yit−1, δit ∼ Normal(ZTitθi2, σ22)
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whereXit = [XTi , Yit−1, log(Ait),XTi log(Ait), Yit−1 log(Ait)]T andZit = (XTi , Yit−1, δit,XTi δit, Yit−1δit)T .
Although this first-stage model is relatively simple, the overall model is flexible when inte-
grated over the random effects Θi. For example, compliance δit/Ait depends on both covariates
and current disease status, and these relationships are individualized through θi1. Similarly, the
individualized treatment effect is controlled by θi2 and the induced relationship between δit, Yit−1,
and Yit. Also, prior correlation between θi0 and θi2 can accommodate effect modification between
the baseline covariates and time between visits in the PMU model. Of course, even more flexi-
ble models can be constructed using non-linear terms in Xit and Zit and higher-order lags in the
Markov model.
Let g be the random effects density, such that Θi
iid∼ g(Θ). Rather than selecting a parametric
model for g, we treat the density as an unknown quantity to be estimated from the data. The prior
for g is modeled using the Dirichlet process prior (Ferguson, 1973; Sethuraman, 1994), which can
be written as g(Θ) =
∑L
l=1 ωl1∆l(Θ), where L = ∞, the mixture probabilities ωl > 0 satisfy∑∞
l=1 ωl = 1, ∆l = (θ
?T
0l ,θ
?T
1l ,θ
?T
2l )
T ∼ Normal(mb,Σb), and 1∆l(·) is the indicator function with
a point mass at ∆l. The mixture probabilities can be generated from the stick-breaking process:
ωl = Vl
∏
h<l(1 − Vh), Vl ∼ Beta(1, α0). The covariance matrix Σb is taken to be block diagonal
with Cov(θ?jl) = Σbj and Cov(θ
?
jl,θ
?
kl) = 0. For priors, we select mb ∼ Normal(0, I) and
Σbj ∼ InvWishart(pj + 1, (pj + 1)Ipj), where pj is the dimension of θ?jl. With these priors and
truncation at a finiteL, all full conditional distributions are conjugate and so we use Gibbs sampling
to obtain posterior samples as described in the supplemental material.
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5 Policy search
Although other classes of policies are possible, such as trees (Laber and Zhao, 2015) and lists
(Zhang et al., 2015), we consider policies defined by a linear risk score. Let the risk score be
Rt = f(Ht)Tα, where f(Ht) is a q-vector of features andα = (α1, . . . , αq)T are their weights. Our
general framework can easily accommodate non-linear relationships between patient characteris-
tics and the risk score by including non-linear summaries of the characteristics as features. As an
extreme example, we could include B-spline basis or tree expansion of a variable as features to give
an arbitrarily flexible risk score. We could also include an interaction between a characteristic and
disease status to account for different importance of the characteristic as the disease progresses.
However, our goal is to develop a policy that is interpretable to domain experts so that it can be
integrated to the clinical practice. Hence, we decided to keep the risk score simple. We describe
the method assuming two possible recommendations, a1 and a2. The policy takes the form
At = pi(Ht;α) =

a1 Rt > κ(α)
a2 Rt ≤ κ(α)
(3)
where κ(α) is the risk threshold that depends on α; more than two treatments could be accommo-
dated using multiple thresholds. With only a single threshold, the scale of α is irrelevant, and so
we impose the restriction ||α|| = (∑qj=1 α2j )1/2 = 1. Figure 3 illustrates how the proposed method
is used when a sequence of recall intervals needs to be optimized under a given policy in terms of
α.
We select the policy parametersα so that when the population of patients follows this rule over
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Figure 3: Illustration of how to optimize a sequence of recall intervals under a given policy using the
proposed method. In this hypothetical example, the risk score Rt is a linear combination of the current
disease statue (Yt) and a single covariate (X), and the two actions are to return in 3 or 9 months.
𝑅𝑡 = 𝛼1𝑌𝑡 + 𝛼2𝑋
𝐴𝑡 =  
3 𝑅𝑡 > 0
9 𝑅𝑡 < 0𝑅1 > 0
Baseline
Recommendation
Policy
𝐴1 = 3
𝑅1 < 0
𝐴1 = 9
𝑅3 > 0 𝐴3 = 3
𝑅3 < 0 𝐴3 = 9
𝑅3 > 0 𝐴3 = 3
𝑅3 < 0 𝐴3 = 9
𝑅3 > 0 𝐴3 = 3
𝑅3 < 0 𝐴3 = 9
𝑅3 > 0 𝐴3 = 3
𝑅3 < 0 𝐴3 = 9
𝑅2 > 0
𝐴2 = 3
𝑅2 < 0 𝐴2 = 9
𝑅2 > 0
𝐴2 = 3
𝑅2 < 0 𝐴2 = 9
time, the long-term average reward is high. Given the posterior of the random effects distribution
g and covariance parameters S = {Σ, σ1, σ2}, the optimal feature weight α is given by
αopt = arg max
α
V (α) such that C(α) = T. (4)
However, this is a challenging optimization problem, because both V (α) and C(α) are expecta-
tions with respect to the predictive distribution of H given g and S. Both V (α) and C(α) are
approximated using Monte Carlo sampling. The MCMC algorithm described in Section 4 pro-
duces J posterior draws {g(j),S(j); j = 1, . . . , J}. For each candidate α and κ(α), we simulate
subject i = 1, . . . , n0 by first sampling j randomly from {1, . . . , J}, then Θi ∼ g(j), and finally Hi
from (2) given Θi and S(j), with recommendations given by pi(Hit;α). Note that in these simula-
tions, the actions taken affect the future outcomes & thus future recommendtaions, and in this way
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the method can allow for delayed effects.
For each candidate α, we first identify the threshold κ(α) that satisfies the cost constraint
C(α) ≈ T , and then estimate the value V (α) given this threshold. We estimate C(α) separately
for a grid of 10 thresholds spanning the range of Rt in the training data, smooth the estimates
using LOESS (Cleveland and Devlin, 1988), and then compute the κ that gives C(α) ≈ T . For
each of the 10 candidate thresholds, we draw n1 = 2, 000 independent subjects’ Hi and use the
sample mean of the n1 averaged recommended recall time as the estimate of C(α). Given the
threshold κ(α), the value V (α) is approximated by another round of Monte Carlo simulation of
n2 = 20, 000 subjects.
We utilize response-surface sequential optimization methodology (Mason et al., 2003) to iden-
tify the value of α that maximizes V (α). The objective function of this optimization is noisy
because only a Monte Carlo estimate of the value is available. In the first stage, we evaluate the
value using a central composite design for α (Montgomery, 2008), scaled to ||α|| = 1. That is,
we consider the M1 = 5q − 1 unconstrained values α˜ ∈ {−2,−1, 0, 1, 2}q (excluding the zero
vector), and then the corresponding constrained vectors αl = (αl1, . . . , αlq)T formed by setting
αlj = α˜lj/
√∑q
h=1 α˜
2
lh, such that ||αl|| = 1. A Monte Carlo estimate of the value Vˆl is computed
for each αl, giving M1 pairs {αl, Vˆl}.
For a given α, the value can be estimated using extensive simulation from the DPM model.
However, when searching for the next α to consider, we need a quick approximation to the value
to avoid spending too much time simulating the value for poor policies. Using these training data,
we fit a Gaussian process regression model to quickly predict the value of a new policy (viaα), and
guide the remaining optimization steps. The value is modeled as a Gaussian process with E(Vˆl) =
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µV , Var(Vˆl) = σ2V , and correlation Cor(Vˆl, Vˆk) = (1− r)I(l = k) + r exp[−
∑q
j=1 φj(αlj −αkj)2].
We set µV and σ2V to the sample mean and variance of Vˆl, respectively. The correlation parameter
r is set to 0.99; the maximum likelihood estimates of r were near one which led to computational
issues with singular covariance matrices, that where alleviated by setting r = 0.99 (Gramacy and
Lee, 2012). With these parameters fixed, we compute maximum likelihood estimates φ1, . . . , φq.
We simulate the values VˆM1+1,. . . ,VˆM1+M2 corresponding to an additional M2 = 200 feature
weights αM1+1,. . . ,αM1+M2 using the sequential optimization criteria of Jones et al. (1998). The
policy weights at step l > M1 are selected to optimize the expected gain in the optimal value. Let
V˜l = max{Vˆ1, . . . , V˜l−1} be the maximum value observed prior to step l, and define the expected
increase in the maximum value if we take an additional sample at α as
G(α) = Φ
[
m(α)− V˜l
s(α)
] [
m(α)− V˜l
]
+ s(α)φ
[
m(α)− V˜l
s(α)
]
,
where m(α) and s(α) are the predictive mean and standard deviation of Vˆ atα from the Gaussian
process regression model using the first l − 1 observations, and Φ and φ are the standard normal
distribution and density functions. To approximate the maximizer of G(α), we randomly generate
1,000 α, scale them so ||α|| = 1, compute G(α) for each α, and take αl to be the α with
the largest G(α). The final estimate is the α that maximizes m(α), the predictive mean from
Gaussian process regression given theM1 +M2 training points. This optimization is approximated
by sampling M3 = 20, 000 weights α1, . . . ,αM3 , scaling them so that ||α|| = 1, and computing
αopt ≈ arg max
α∈{α′1,...,α′M3}
m(α). (5)
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With these specifications, the optimization requires approximately 75 minutes on a standard
desktop computer for the simulated cases described in Section 6. However, this rudimentary R
code does not exploit the obvious opportunities to parallelize over the subjects within the Monte
Carlo simulations for a given α or across simulations for different α. Therefore, it should be
possible to scale this approach up to larger problems than those considered here. The R package
DiceOptim (Roustant et al., 2012) performs stochastic optimization using similar steps as our
algorithm, so users may be able to use this package to avoid extensive coding for some of the
proposed optimization steps.
MCMC produces posterior draws of the random effects distribution and covariance parameters,
f (s) and S(s), for s = 1, . . . , S MCMC samples. Each posterior sample corresponds to a different
αopt. Applying this optimization for each posterior draws produces a posterior distribution for
αopt, which is used for uncertainty quantification.
6 Simulation study
Each dataset consists of n subjects generated independently from (2). There are p = 2 baseline
covariates, the variance parameters are σ1 = 0.1 and σ2 = 0.5, and Σ0 is the correlation matrix
with 0.5 for all off-diagonal elements. Subjects are generated from two groups, with the group
identifier for subject i denoted Gi ∈ {1, 2}. Subjects from the first group are generated as
17
(XTi , Yi0)
T |Gi = 1 ∼ Normal(0,Σ0) (6)
log(δit)|Yit−1, Ait, Gi = 1 ∼ Normal
[
log(Ait)(0.9 + 0.1Xi1), σ
2
1
]
Yit|Yit−1, δit, Gi = 1 ∼ Normal
[
0.1 + 0.2Xi2 + 0.2(δit − 6) + 0.9Yit−1 + 0.02(δit − 6)Yit−1, σ22
]
.
Subjects from the second group are generated as
(XTi , Yi0)
T |Gi = 2 ∼ Normal
[
(1, 0, 0)T ,Σ0
]
(7)
log(δit)|Yit−1, Ait, Gi = 2 ∼ Normal
[
log(5.3), σ21
]
Yit|Yit−1, (δit − 6), Gi = 2 ∼ Normal
[
0.1 + 0.3Xi1 − 0.2(δit − 6) + 0.9Yit−1, σ22
]
.
Unlike the first group, the second group of subjects are non-compliers in that the recommenda-
tion Ait does not affect the distribution of the time until next visit. For simulated training data,
recommendations are either Ait ∈ {3, 9} with logit[Prob(Ait = 3)] = Yit−1. For each subject,
we simulate observations until the subject has been in the study for five years. We consider two
scenarios by varying the cluster assignment probability. The cluster assignment is either “Single
group” with Prob(Gi = 1) = 1 or “Mixture model” with Prob(Gi = 1) = 0.8. The sample size
is n = 1, 000. We simulate 100 datasets from each scenario. The supplemental materials include
additional simulations with binary covariates and misspecified models.
We consider two different utility functions: U(H) = −1/N∑Nt=1 Yt (“average”), which fo-
cuses the policy to reduce large values of Yt; U(H) = Y0 − YT60 (“reduction”), which aims to
maximize the reduction of PMU in 5 years from baseline, where YT60 is the response for a subject
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in 5 years (60 months) since baseline visit (if no visit occurs at the exact time point, interpolation
is used to estimate the response value). We compare four methods. The “baseline” policy recom-
mends At = 6 months between visits for all subjects and t. The remaining three methods use the
policy in (3) with a1 = 3 and a2 = 9. The risk score is a linear combination of q = 4 features
representing the two baseline covariates (X1 andX2), non-compliance (via log(|δt−1−At−1|+1)),
and disease status (via Yt−1):
Rt = X1α1 +X2α2 + log(|δt−1 − At−1|+ 1)α3 + Yt−1α4
with A0 = δ0 = 6. We compare two methods that estimate α and κ(α) by fitting the n training
observations with either a “Gaussian” model or “DPM” model, and then approximating the value
using the posteriors of g and S as described in Section 5. For the DPM model, we use L = 5
mixture components, and for the Gaussian model, we use the DPM model with L = 1. We also
compare the “oracle” policy which computes α and κ(α) by simulation assuming the true values
of the model parameters in (6) and (7). Of course, in a real data analysis, this would be impossible,
but we include this in the simulation study as a reference. The hyperparameter values and MCMC
details are described in the supplemental material.
The Gaussian and DPM models are fitted to the data using MCMC sampling with J = 5000
iterations. For these methods, the policy viaα and κ(α) is computed using Monte Carlo simulation
given posterior samples, using the fit to the training data. After estimating the policy, the averaged
recommended recall time and value of these methods are approximated using sample means over
1,000,000 Monte Carlo draws, assuming the true parameter values in (6) and (7). For each of
the 100 simulated datasets, we estimate one optimal policy and the value corresponding to the
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estimated optimal policy for each utility function. Table 1 reports the mean of the 100 values
and average recommended recall time over the 100 simulated datasets for each scenario and each
utility function. Since the standard error is bounded by 0.01, we present the sample means by
rounding them to two decimal places. For the baseline policy, there are no policy parameters to
be estimated, hence the value is simply approximated using sample means over 1,000,000 Monte
Carlo draws given the true parameter values. The oracle model requires estimating α and κ(α),
but the estimates α and κ(α) do not depend on the training data.
All three adaptive policies have larger (better) value than the static baseline policy in all cases.
For data generated from a single group, the Gaussian model is correct and produces value nearly
identical to the oracle policy. The DPM approach is also nearly identical to the oracle model in
this case, showing that little is lost in fitting a complex model in this simple case. When data are
generated from the two-component mixture model that includes non-compliers, the misspecified
Gaussian model gives a policy with suboptimal value and averaged recommended recall time that
exceeds the six-month threshold. For the mixture model, the DPM approach provides a substantial
improvement over the Gaussian model.
To gain further insight about the effects of model misspecification, Figure 4 plots the sampling
distribution of the estimated policy weights αopt for each method, scenario and utility function.
Both the Gaussian and DPM methods give αopt near the oracle model for the single-group sce-
nario. In this case, the previous value of Y is the most important feature and thus the policy is
to recommend shorter recall times for unhealthy subjects. The estimated αopt under the Gaussian
model disagree with the oracle policy for data generated under the mixture model. For example,
the importance of non-compliance is underestimated. In contrast, the oracle model in Figure 4 (c)
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Table 1: Simulation study results comparing the baseline model with 6-month recommendation for all
subjects, policy search methods based on Gaussian and Dirichlet process mixture (DPM) fits, and the oracle
model which uses the true data-generating model to estimate the policy. The standard errors of the sample
means are all less than 0.01.
Cluster Utility Value (larger is preferred)
Allocation Function Baseline Gaussian DPM Oracle
Single Average -0.67 -0.09 -0.09 -0.09
Single Reduction -0.87 -0.05 -0.05 -0.05
Mixture Average -1.01 -0.63 -0.58 -0.58
Mixture Reduction -1.42 -0.86 -0.83 -0.83
Cluster Utility Average recommended recall time
Allocation Function Baseline Gaussian DPM Oracle
Single Average 6.00 5.99 5.99 6.00
Single Reduction 6.00 5.99 5.99 6.00
Mixture Average 6.00 6.07 5.99 6.00
Mixture Reduction 6.00 6.07 5.99 6.00
gives considerable weight to non-compliance to account for non-compliers.
Model misspecification for the Gaussian case also affects the estimated value and average rec-
ommended recall time of the policy. Figure 5 shows that the value is generally larger, thus overly
optimistic when evaluated using Monte Carlo simulations under the incorrectly fitted model than
the true mixture model. In practice, value must be estimated under the fitted model, which can be
misleading if the model is incorrect.
The optimal α in (4) is a deterministic function of the model parameters g and S. Thus far,
we have been averaging over uncertainty in g and S to obtain an optimal policy. However, to
quantify uncertainty in the policy, we can inspect the posterior distribution of αopt induced by the
posterior distribution of g and S . To illustrate, we simulate 100 datasets generated from the two-
component mixture model. We randomly select posterior samples {g(j),S(j); j = 1, . . . , 20} from
all J posterior draws produced by fitting the DPM model to the data. Given each selected posterior
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Figure 4: Estimated optimal feature weights αopt for the simulation study. The boxplots for the Gaussian
and DPM methods show the estimated αopt over the 100 simulated datasets; the solid points represent αopt
for the Oracle policy. The risk score is a linear combination the two baseline covariates (X1 and X2),
non-compliance (“Non-comp”; log(|δt−1 −At−1|+ 1)), and disease status (“Cur Y”; Yt−1):
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Figure 5: Value and average recommended recall time for the 100 datasets for the policy (via αopt) esti-
mated using the Gaussian model or DPM model for data generated from a two-component mixture model
with n = 1, 000 subjects using reduction utility function. The value and average recommended recall time
of the policy are evaluated using Monte Carlo samples under the true model used to generate the data and
the estimated Gaussian model or DPM model.
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sample of model parameters, a posterior αopt is estimated using reduction utility function. We
estimate 90% credible intervals of αopt for each of the 100 simulated datasets. More specifically,
for each simulated dataset, we estimate the optimal policy corresponding to each of the posterior
draw of g and S to obtain the posterior distribution of the optimal weight αopt. The coverage rates
of credible intervals for optimal α1, α2, α3, α4 are 96%, 95%, 98%, 100% respectively, which
indicates that our estimated credible intervals are conservative and reliable.
7 Analysis of the HealthPartners data
7.1 Tailoring the BNP model to the HP data
The DPM model in (2) must be generalized to incorporate the complexities of the HP data. In the
HP data, the baseline covariate vector Xi includes gender (Xi1), race (Xi2), standardized age (Xi3),
diabetes status (Xi4), smoking status (Xi5) and commercial insurance indicator (Xi6). In the final
model, we include covariates, such that Xit = [XTi , Yit−1, log(Ait),XTi log(Ait), Yit−1 log(Ait)]T
and Zit = [XTi , Yit−1, log(δit),XTi log(δit), Yit−1 log(δit)]T . Because Xi1, Xi2, Xi4, Xi5 and Xi6
are binary, we introduce latent continuous variables X?i to link the binary covariates to the DPM
model, Xij = I(X?ij > 0) for j = 1, 2, 4, 5, 6. For identification, we restrict the variance of X
?
i1,
X?i2, X
?
i4, X
?
i5, X
?
i6 to be 1. Also, with responses taking values only in [0, 1], we use the Tobit model
(Tobin, 1958) to link the response to a continuous latent variable Y ? whose support is (−∞,∞),
and the observed variable is related to the continuous variable as Y˜it = Y ?it if 0 ≤ Y ?it ≤ 1, Y˜it = 0
if Y ?it < 0 and, Y˜it = 1 if Y
?
it > 1.
Then (X?Ti , Y ?i0)T ∼ Normal(θi0,Σ0) and Y ?it ∼ Normal(ZTitθi2, σ22).
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After fitting the model to the HP data, diagnostic checks revealed evidence against the normal-
ity assumption. Therefore, we use scale mixtures of normals to accommodate the heavier-tailed
residual distributions, such that
log(δit)|Θi,Xi, Yit−1, Ait ∼ Normal(X Tit θi1, λit1σ21)
Y ?it |Θi,Xi, Yit−1, δit ∼ Normal(ZTitθi2, λit2σ22)
where λit1 ∼ Inv-Gamma(ν1/2, ν1/2), λit2 ∼ Inv-Gamma(ν2/2, ν2/2). Also, as shown in Figure
1, there are number of observations with yit = yit−1. To account for this, we adjust the disease-
progression model such that Yit can have excess probability pit on yit−1,
f(y|Yit−1 = yit−1) = pit1yit−1(y) + (1− pit)φ?(y|ZTitθi2, λit2σ22)
where pit = Φ(ZTitθi3), 1yit−1(·) is the indicator function with a point mass at yit−1, and φ?(y|ZTitθi2, λit2σ22)
is the density of the response variable Y˜it in the Tobit model with mean ZTitθi2 and variance λit2σ22 ,
which corresponds to a normal distribution for the latent response variable Y ?it . We assign the
Dirichlet process prior for the distribution of Θi = {θi0,θi1,θi2,θi3}. The hyperparameter val-
ues and MCMC details are described in the supplemental material. The supplemental materials
also include model comparisons and goodness of fit diagnostics. We find that the DPM model de-
scribed in this section withL = 10 mixture components fits well and outperforms simpler methods.
Therefore we use this model for the remainder of the analysis.
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7.2 Summarizing the fitted model
The posterior mean and standard deviation for average of (θ?T1l ,θ
?T
2l ,θ
?T
3l )
T weighted by the mixture
probabilities wl for l = 1, 2, . . . , 10 are listed in Table 2. As expected, the recommended recall
interval (Ait) is the most important factor to determine the actual recall time (δit), and current
disease status (Yit−1) is the most important predictor to predict the disease status during next visit
(Yit). The disease progression between two visits is associated with the actual time between two
visits, and the significantly positive interaction effect between current disease status and actual
recall time on Y ?it indicates that time effect is larger for subjects with worse disease status. Also,
most of the baseline covariates have significant effect on either the actual recall time or disease
progression.
Table 2: The posterior mean ×100 and standard deviation ×100 for weighted average of random effects
with log(δit), Y ?it and Φ
−1(pit) as responses, respectively. The posterior mean with “?” represents the
corresponding 95% credible intervals that excludes zero.
Response Recall time (log(δit)) PMU (Y ?it ) Prob equal (Φ
−1(pit))
Mean SD Mean SD Mean SD
Intercept 84.63? 6.41 Intercept -1.76? 0.38 -47.83? 9.10
Gender -0.41 1.43 Gender -0.16 0.11 6.84 3.44
Race 24.75? 2.81 Race -0.25 0.20 1.42 5.33
Age -10.41? 0.92 Age 0.47? 0.08 -1.08 2.55
Diabetes -4.16 4.98 Diabetes -0.36 0.26 -13.87 6.99
Smoking -17.87? 3.02 Smoking 0.98? 0.23 -9.89 6.77
Insurance -23.10? 5.65 Insurance 2.44? 0.30 7.71 7.66
Yit−1 -37.24? 8.43 Yit−1 89.67? 0.72 92.70? 16.68
log(Ait) 63.92? 3.45 log(δit) 1.33? 0.17 16.36? 4.37
Gender∗ log(Ait) 0.21 0.67 Gender∗ log(δit) 0.15? 0.05 3.36? 1.54
Race∗ log(Ait) -11.95? 1.32 Race∗ log(δit) 0.00 0.09 -3.72 2.49
Age∗ log(Ait) 3.12? 0.45 Age∗ log(δit) -0.03 0.04 0.07 1.25
Diabetes∗ log(Ait) 2.33 2.73 Diabetes∗ log(δit) 0.26? 0.12 7.62? 3.04
Smoking∗ log(Ait) 9.47? 1.63 Smoking∗ log(δit) -0.14 0.11 10.50? 3.33
Insurance∗ log(Ait) 10.63 3.14 Insurance∗ log(δit) -1.28? 0.15 1.31 3.72
Yit−1 ∗ log(Ait) 17.76? 4.05 Yit−1 ∗ log(δit) 3.61? 0.31 2.77 7.52
26
7.3 Summarizing the fitted policy
While analyzing HP data, we use the policy in (3) with a1 = 3 and a2 = 9, and a linear combination
of q = 4 features representing standardized age (X3), diabetes status (X4 = 0 for subjects without
diabetes, and X4 = 1 for subjects with diabetes), non-compliance (via log(|δt−1−At−1|+ 1)) and
disease status (via Yt−1). As the scale of Yt−1 is much smaller than the other three features, we use
10Yt−1 in the risk score to get more stable estimates of the feature weights:
Rt = X3α1 +X4α2 + log(|δt−1 − At−1|+ 1)α3 + 10Yt−1α4.
We have also tried replacing diabetes status (X4) with gender (X1) or smoking status (X5) in the
construction of the risk score, and this does not improve the value V . We define the utility function
as the reduction in proportion of unhealthy sites in 5 years from baseline U(H) = Y0−YT60 , where
YT60 is the response for a subject in 5 years (60 months) since baseline visit (if no visit occurs at
the exact time point, interpolation is used to estimate the response value), and control the cost by
constraining average recommended recall time to be C(α) = 6 months. We use 5, 000 iterations
in Gibbs sampling, and discard first 3, 000 burn-in samples to obtain 2, 000 posterior samples by
fitting the DPM model. We randomly draw 100 posterior samples of g and S and estimate optimal
policy in terms of αopt given each selected posterior draw.
Figure 6 plots the posterior ofαopt. The posterior mean weights for diabetes and non-compliance
are positive. This suggests that subjects with diabetes and non-compliers should be recommended
to come back to the dental clinic in a shorter time, reconfirming earlier findings on the link be-
tween diabetes and PD (Mealey and Oates, 2006), and between recall compliance and medium to
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long-term PD therapy (Fenol and Mathew, 2010). However, the posterior distribution of the weight
for diabetes has a large variance. The weight for the current disease status is significantly positive
with high value, which indicates that the current disease status is an important feature in deter-
mining recommendation decision, and the subject with a higher proportion of diseased sites has
a higher risk score and should be assigned shorter recall time. The negative estimated weight for
age indicates that younger subjects should have more frequent visits. It may be that younger sub-
jects are less stable, and so providing more visit opportunities to younger subjects might improve
population-level benefits.
We also estimate one final optimal policy αopt averaging over uncertainty in g and S, which
gives the risk score functionRt = −0.17X3 +0.50X4 +0.22 log(|δt−1−At−1|+1)+8.2Yt−1 with a
threshold 1.06. This risk score function suggests that subjects with diabetes tend to have higher risk
than subjects without diabetes, and the disease status is the most important feature that decides the
recommended recall time. For example, a subject with diabetes, average age (X3 = 0) and perfect
compliance (δt−1 = At−1) should come back in 3 months if his/her proportion of unhealthy sites is
higher than 6.8%. A subject without diabetes and with average age and perfect compliance should
come back in 3 months if his/her proportion of unhealthy sites is higher than 12.9%.
The value corresponding to the estimated optimal policy is V (αopt) = −0.0102 with standard
error 0.0002, which is estimated by Monte Carlo Simulation with 100, 000 simulated subjects.
Compared to the ‘baseline’ policy which recommends At = 6 months between visits for all sub-
jects and t and with estimated V = −0.0170 with standard error 0.00018, the utility value averag-
ing over the entire distribution of H increases by about 40%. This is a substantial improvement,
especially when the improvement of expected value is multiplied by the number of people in the
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Figure 6: Posterior distribution (5th, 25th, 50th, 75th, 95th percentiles) of optimal feature weights αopt for
the HP data analysis. The features are age (standardized), diabetes (with diabetes=1 and without diabetes=0)
non-compliance (log(|δt−1 −At−1|+ 1)), and current response (Yt−1).
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population.
Furthermore, to explore the effects of choosing a linear function of the subject characteristics
and current disease status as the risk score, we updated the policy with a quadratic term of current
disease status (the most important feature) in constructing the risk score. The estimated risk score
is Rt = −0.38X3 + 0.55X4 + 0.25 log(|δt−1 − At−1| + 1) + 3.2Yt−1 + 63Y 2t−1, with the value
−0.0101, which is very close to the value −0.0102 corresponding to the optimal policy under the
class of policies with only linear function of the features. Hence, we advocate using only linear
features for this dataset.
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8 Conclusions
Motivated to address the shortcomings of the classic 6-month recall interval in periodontal treat-
ment allocations, we present a policy-optimized recommendation engine using BNP that exhibits
superior performance, compared to alternatives. We show using simulation studies that the pro-
posed method provides a valid posterior inference, and can reliably identify the optimal policy.
Applying the method to the HP data, we find that the optimal policy recommends more frequent
visits for young, unhealthy non-compliers, and that following this policy could lead to a substantial
reduction in PD.
A number of computerized periodontal risk assessment tools are currently available (Page et al.,
2003; Persson et al., 2003). For example, the Cigna PD self-assessment tool available at https:
//www.cigna.com/healthwellness/tools/periodontal-quiz-en considers subject-
specific inputs through a questionnaire, and combines information from the PD fact sheet of the
American Academy of Periodontology to calculate a simple ordinal risk score (low, low to moder-
ate, moderate, or high), without any guidance towards recall intervals. There exists a number of
popular chairside software in practice-based dentistry (such as Patterson’s Eaglesoft®) that record
and display data. Supplementing these tools with an evidence-based recommendation system for
periodontal recalls would aid practitioners.
A limitation of our analysis is that we use periodontal pocket depth (PPD) rather than the most
reliable endpoint (AAP, 2005), the clinical attachment level (CAL). Site-level full mouth CAL
assessment in a practice-based observational data setting like ours is time-consuming and techni-
cally demanding (Michalowicz et al., 2013). For example, in the HP dataset, CAL is computed
only for the mid-buccal and mid-lingual sites, whereas, the PPD is calculated for all 6 sites on
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each tooth (if that tooth is present). Also, since CAL is computed from two other measures, it
is more prone to error, and less reproducible than PPD (Osbom et al., 1992; Hill et al., 2006).
Hence, we considered thresholded site-level PPD in addition to missing tooth to compute the pro-
portion subject-level endpoints. The missing tooth in our analysis is assumed missing due to past
incidence of PD, and the error generated from the apparent misclassification of the missingness
source (such as, tooth falling out due to mechanical injury) is usually negligible while analyzing
large observational databases. Should CAL and PPD measures become available for all sites (in
other databases), our framework can readily incorporate this information. In addition, to reduce
computational burden, our present policy only considers recall intervals of 3 and 9 months. Our
method can be easily extended to more than two possible actions by adding thresholds to the risk
score. Computationally, estimating an optimal threshold parameter should be similar to estimating
a feature weight. Therefore, the proposed decision framework is quite general, and can be adapted
to the specific needs of the practitioner.
To the best of our knowledge, this is the first study to cast the century-old debate on periodon-
tal recall intervals into a DTR stochastic framework. Our recommendation tool is derived from
a specific US midwestern population, and it’s generalizability should be tried with caution. Lon-
gitudinal PD databases from other practice-based settings (such as Kaiser Permanente®) maybe
combined with the current HP database to refine findings. Furthermore, our present recall engine
is geared exclusively towards PD assessment; and do not include (dental) caries risk, although
evidence suggest that they may occur simultaneously (Mattila et al., 2010). These are potential
directions for future work, to be pursued elsewhere.
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